Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Primary Signet Ring Cell Carcinoma of the Urinary Bladder

´ëÇѺñ´¢±â°úÇÐȸÁö 2009³â 50±Ç 2È£ p.188 ~ 191
Á¤¼ºÈ¯, Á¤¼öÁø, ¹Î±Ç½Ä, Á¤ÀçÀÏ, ÃÖ¼ºÇù, °­µ¿ÀÏ,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤¼ºÈ¯ ( Jung Sung-Hwan ) 
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Á¤¼öÁø ( Jung Soo-Jin ) 
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ºÎ»ê¹éº´¿ø º´¸®Çб³½Ç
¹Î±Ç½Ä ( Min Kweon-Sik ) 
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
Á¤ÀçÀÏ ( Chung Jae-Il ) 
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
ÃÖ¼ºÇù ( Choi Sung-Hyup ) 
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
°­µ¿ÀÏ ( Kang Dong-Il ) 
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Abstract


Primary signet ring cell carcinoma of the urinary bladder is a relatively rare histological variant of mucus-producing adenocarcinoma usually of poor prognosis. We report two cases of primary bladder signet ring carcinoma. The first patient underwent a radical cystectomy with ileal conduit (pT3bN1M0), radiotherapy, and chemotherapy (M-VAC regimen) and subsequently expired 37 months after surgery. The other was initially diagnosed with peritoneal metastasis from the primary bladder signet ring cell carcinoma and was treated with partial cystectomy (pT3bNOM1). Postoperative adjuvant therapy was not done because of patient¡¯s refusal.

Å°¿öµå

Carcinoma;signet ring cell;Urinary bladder

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS